Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
10-year Follow-up
19%
95% Confidence Interval
33%
Acute Heart Failure
27%
Acute Myocardial Infarction
27%
All-cause Mortality
42%
Aortic Stenosis
19%
Atrial Fibrillation
100%
C-reactive Protein
24%
Cardiovascular Events
21%
Cardiovascular Mortality
22%
Clarithromycin
24%
Computed Tomography
16%
Copenhagen
20%
Coronary Artery Disease
30%
Denmark
17%
Early-onset Atrial Fibrillation
20%
Elderly Subjects
19%
Excessive Supraventricular Ectopic Activity
18%
Hazard Ratio
55%
Heart Disease
34%
Heart Failure
17%
Heart Rate Variability
30%
Incident Atrial Fibrillation
25%
Infarction
29%
Ischemic Stroke
29%
Left Atrial Function
24%
Liraglutide
45%
Metformin
23%
Middle-aged
38%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
29%
New-onset Type 2 Diabetes
25%
Night-time Heart Rate
15%
Non-severe
19%
Older Subjects
18%
Patients with Coronary Artery Disease
28%
Placebo
42%
Poor Prognosis
16%
Population-based
19%
Prognostic Significance
16%
Prognostic Value
15%
Pulmonary Congestion
15%
Randomized Trial
20%
Risk Factors
18%
Silent Myocardial Ischemia
19%
Stable Coronary Artery Disease
65%
Stroke Risk
16%
Systolic Blood Pressure
23%
Type 2 Diabetes Mellitus (T2DM)
43%
Ventricular Arrhythmia
17%
Verapamil
25%
Medicine and Dentistry
Acute Decompensated Heart Failure
27%
Acute Heart Infarction
18%
All Cause Mortality
32%
Amino Terminal Sequence
15%
Aortic Stenosis
25%
Aortic Valve Stenosis
12%
Apoplexy
30%
Atrial Fibrillation
62%
Beta Cell
13%
Blood Pressure
27%
Brain Ischemia
16%
Brain Natriuretic Peptide
17%
C Reactive Protein
17%
Cardiovascular Disease
16%
Cardiovascular System
23%
Cohort Analysis
20%
Computer Assisted Tomography
23%
Congestive Heart Failure
26%
Coronary Artery Disease
80%
Diseases
15%
Dyspnea
14%
Echocardiography
16%
Electrocardiogram
15%
Glucagon-Like Peptide-1 Agonist
20%
Glucose
17%
Glycon
22%
Hazard Ratio
44%
Heart Disease
24%
Heart Left Ventricle Ejection Fraction
12%
Heart Rate Variability
29%
Hypertension
15%
Inflammation
14%
Liraglutide
58%
Long Term Exposure
13%
Lung Congestion
15%
Maturity Onset Diabetes of the Young
62%
Middle Age
28%
Myocardial Infarction
24%
Nonsustained Ventricular Tachycardia
15%
Observational Study
20%
P Wave
12%
Patient with Type 2 Diabetes
18%
Placebo
48%
Prevalence
14%
Randomized Clinical Trials
13%
Randomized Controlled Trial
13%
Silent Myocardial Ischemia
12%
Systolic Blood Pressure
23%
Traffic Noise
12%
Troponin T
23%